L'Ecuyer, Katia (Utah Valley University)
Faculty Advisor: Gazdik Stofer, Michaela (Utah Valley University, Microbiology)
Streptococcus agalactiae most commonly known as Group B streptococcus (GBS), are encapsulated gram-positive bacteria encountered in approximately 15-40% of pregnant women's urogenital and gastrointestinal tracts. While most women are asymptomatic, GBS colonization of newborns as they pass through the birth canal can lead to sepsis. GBS bloodstream infections are the leading cause of mortality and morbidity amongst infants in the United States. In recent years, several studies have examined the benefits of oral probiotics to promote a healthy vaginal flora and assessed the inhibitory activity of lactobacilli against urogenital pathogens, with mixed results. The purpose of our research is to examine the effect of Lactobacilli on the growth of different GBS serotypes in the vaginal environment using in vitro culture competition experiments. Previously published microbiome studies were used to determine the dominant species found in the vaginal microbiota. We are examining the growth rate of GBS when co-cultured with vaginal microflora species, both individually and as a mixed community. This will provide a baseline regarding what strains of GBS could easily colonize the vagina in high levels when in competition with different normal flora communities. Different species of probiotic Lactobacilli will then be added to the vaginal culture collection to examine if there is an effect on GBS growth. Our goal is to identify probiotic species that prevent or slow the growth of GBS in a vaginal community.